UCB SA (EBR:UCB)
Belgium · Delayed Price · Currency is EUR 256.40
-1.50 (-0.58%)
At close: Jan 20, 2026
UCB SA Market Cap
UCB SA has a market cap or net worth of €49 billion as of January 20, 2026. Its market cap has increased by 31.24% in one year.
Market Cap
49.00B
Enterprise Value
50.27B
Revenue
6.85B
Ranking
n/a
PE Ratio
37.56
Stock Price
€256.40
Market Cap Chart
Since April 5, 1995, UCB SA's market cap has increased from 890.67M to 49.00B, an increase of 5,401.50%. That is a compound annual growth rate of 13.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 19, 2026 | 49.00B | 8.09% |
| Dec 31, 2025 | 45.33B | 24.32% |
| Dec 31, 2024 | 36.46B | 143.60% |
| Dec 29, 2023 | 14.97B | 7.12% |
| Dec 30, 2022 | 13.97B | -26.25% |
| Dec 31, 2021 | 18.95B | 18.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| argenx SE | 42.45B |
| Financière de Tubize | 10.48B |
| Fagron NV | 1.68B |
| Ion Beam Applications | 410.90M |
| Hyloris Pharmaceuticals | 221.20M |
| Onward Medical | 202.43M |
| Nyxoah | 186.95M |
| Sequana Medical NV | 32.32M |